Syed Suhaib Ahmed | Pharmacology | Young Scientist Award

Prof. Syed Suhaib Ahmed | Pharmacology | Young Scientist Award

Prof. Syed Suhaib Ahmed | Pharmacology | Yenepoya Universtiy | India

Dr. Syed Suhaib Ahmed, M.Pharm., Ph.D., is a dynamic academician and researcher specializing in pharmaceutics and nanomedicine. With a strong foundation in pharmacy, he has advanced his expertise through extensive teaching, research, and scholarly contributions. Currently serving as Assistant Professor at Yenepoya Pharmacy College & Research Centre, Mangalore, he also continues his impactful research journey initiated at JSS College of Pharmacy, Ooty. His Ph.D. project focused on the design and development of surface-conjugated solid lipid nanoparticles co-encapsulating a flavonoid and an anticancer drug for targeted colon cancer therapy. Dr. Ahmed has authored several national and international publications in reputed journals and presented his work at conferences and seminars. His innovative contributions to drug delivery systems, formulation development, and nanotechnology position him as a promising researcher in pharmacology. Recognized with fellowships and grants, Dr. Ahmed embodies academic excellence, research innovation, and a strong commitment to advancing pharmaceutical sciences.

Author Profiles

Orcid | Google Scholar

Education

Dr. Ahmed’s educational foundation reflects his dedication to pharmaceutical sciences. He completed his Bachelor of Pharmacy (B. Pharm.) in 2017 from Nalanda College of Pharmacy, Nalgonda, under JNTUH, securing a solid academic base. To advance his knowledge in drug formulation and delivery, he pursued M.Pharm. (Pharmaceutics) in 2019 at the same institution. His postgraduate research explored “Formulation and in vitro evaluation of doxophylline oral disintegrating tablets,” marking his early entry into formulation design. Driven by a passion for translational research, he enrolled for his Ph.D. (2022–2024) at JSS College of Pharmacy, Ooty, under JSS Academy of Higher Education & Research. His doctoral thesis centered on surface-conjugated solid lipid nanoparticles incorporating irinotecan and daidzein for colon cancer treatment, a study that combined advanced nanotechnology with oncology. This robust academic trajectory highlights his strong theoretical knowledge, practical research expertise, and innovation in pharmaceutics.

Experience

Dr. Ahmed has developed a rich blend of teaching and research experience that strengthens his academic profile. He began his career as a Lecturer at JSS College of Pharmacy, Ooty (Feb 2022 – July 2024), where he taught undergraduate and postgraduate pharmacy students while mentoring research projects. In September 2024, he joined Yenepoya Pharmacy College & Research Centre, Mangalore as an Assistant Professor, further expanding his teaching and mentoring contributions. Alongside academics, Dr. Ahmed has actively engaged in high-impact research, particularly in nanoparticle-based drug delivery systems. His doctoral project on colon-targeted lipid nanoparticles has provided novel insights into cancer therapeutics. Beyond teaching and research, he has attended 29+ conferences, delivered 9 presentations, and participated in 17 workshops, enhancing his professional network and exposure. His expertise in handling advanced instruments like DLS, DSC, XRD, and HPLC, combined with his strong teaching skills, showcases his versatility as both an educator and researcher.

Awards and Honors

Dr. Ahmed’s dedication to pharmaceutical research has been recognized through prestigious awards and fellowships. He was the recipient of the JSSAHER Fellowship, supporting his early-stage Ph.D. research on innovative nanoparticle drug delivery. Additionally, His academic excellence and contributions are further highlighted through multiple opportunities to present his work at national and international platforms. He has actively participated in over 29 conferences, 17 workshops, and 9 oral/poster presentations, gaining recognition for his innovative approaches in pharmaceutics. His scholarly publications in high-impact journals like the International Journal of Biological Macromolecules and Applied Organometallic Chemistry reflect his growing influence in the pharmacology community. These achievements stand as a testament to his perseverance, innovation, and leadership, positioning him as a rising figure in pharmaceutical sciences.

Research Focus

Dr. Ahmed’s research interests lie at the intersection of nanomedicine, targeted drug delivery, and formulation development. His Ph.D. research on solid lipid nanoparticles (SLNs) co-encapsulating irinotecan and daidzein represents a significant step forward in colon cancer therapy, addressing challenges of drug solubility, stability, and targeted delivery. By conjugating nanoparticles with hyaluronic acid and bovine serum albumin, he designed a system capable of actively targeting CD44 and SPARC receptors on colon epithelia, ensuring enhanced therapeutic efficacy. His research includes both in vitro assays on HT-29 colon cancer cells and in vivo studies in Wistar rats, demonstrating translational potential. Beyond oncology, he has contributed to fields like microneedle technology, nanoparticle synthesis, and orphan drug formulation challenges. He is also interested in QbD (Quality by Design) approaches, polymeric drug delivery systems, and risk assessment in pharmaceutical development. His work aims to bridge laboratory innovation with clinical applications, making a tangible impact in pharmacology.

Publications

  1. Oral delivery of SLNs decorated with hyaluronic acid and BSA: Novel colon cancer therapy – IJ of Biological Macromolecules, 2024.

  2. Green synthesis of BSA–silver nanoparticles with anticancer activity – Applied Organometallic Chemistry, 2024.

  3. Exploring multistage nanocarriers for colon cancer treatment – Journal of Research in Pharmacy, 2023.

  4. Challenges in developing generic orphan drugs: US & EU survey – Value in Health Regional Issues, 2023.

  5. Risk assessment in COVID-19 vaccine formulation and transfer – Vitae, 2022.

  6. Folic acid–tailored daidzein SLNs for cytotoxicity against colon cancer – IJ of Applied Pharmaceutics, 2024.

  7. Advancements in microneedle drug delivery systems – IJ of Applied Pharmaceutics, 2024.

  8. Molecular docking studies of benzylidene amino phenyl acetamides – IJ of Applied Pharmaceutics, 2024.

  9. Formulation & evaluation of doxophylline ODTs – Research Journal of Pharmacy and Technology, 2020.

  10. Pharmaceutical product life cycle challenges for generic approvals – Indian J of Pharmaceutical Education & Research, 2022.

Conclusion

Dr. Syed Suhaib Ahmed represents the new generation of pharmacology researchers, combining academic rigor with cutting-edge nanomedicine innovations. His scholarly contributions, teaching excellence, and impactful research on targeted cancer therapies demonstrate his potential to redefine future directions in pharmaceutical sciences. With strong recognition through fellowships, grants, and publications in reputed journals, he is poised to make lasting contributions to pharmacology and translational drug development.

Dr. Muhammad Saleem Khan | Pharmacology | Best Researcher Award

Dr. Muhammad Saleem Khan | Pharmacology | Best Researcher Award

Dr. Muhammad Saleem Khan, University of Okara, Pakistan

Dr. Muhammad Saleem Khan, a Higher Education Commission Approved Supervisor from Pakistan, serves as an Assistant Professor (Zoology) and In-charge of Undergraduate Studies at the University of Okara. With a focus on advancing research in nanotechnology, physiology, human molecular genetics, toxicology, and fishery science, Dr. Khan has made significant strides in interdisciplinary scientific research. His passion for science is evident through his numerous impactful publications in high-ranking journals, highlighting the therapeutic and ecological applications of nanomaterials and his studies on various environmental and biological phenomena. He also oversees a dedicated research lab at the University of Okara and remains an integral member of Pakistan’s academic and research community, promoting innovation and excellence. Dr. Khan’s work has earned national and international recognition, establishing him as a dedicated scientist contributing to advancements in biological and pharmacological sciences.

Professional Profile

scopus

orcid

google scholar

summary of suitability for Best Researcher Award

Dr. Muhammad Saleem Khan is a strong candidate for the Research for Best Researcher Award based on his extensive academic background and significant contributions to the field of Zoology, particularly in nanotechnology, physiology, human molecular genetics, toxicology, and fisheries. Currently serving as an Assistant Professor and In-charge of Undergraduate Studies at the University of Okara, Pakistan, he demonstrates both leadership in academia and an active engagement in impactful research.

🎓 Education

Dr. Muhammad Saleem Khan holds an extensive academic background in Zoology and Education. He earned his Ph.D. in Zoology from GC University Faisalabad in 2017, focusing on advanced biological research and applied sciences. His postgraduate journey began with an M.Phil in Zoology from the same institution in 2011 and an M.Sc. in 2008, both reflecting his commitment to the biological sciences. He also completed a B.Sc. from the University of Punjab in 2005, where he majored in Botany, Chemistry, and Zoology. Prior to his higher education, he built a solid foundation in the sciences with an F.Sc. from BISE Lahore in 2003 and an SSC in 2001, excelling in core subjects such as Biology, Chemistry, and Physics. Further complementing his expertise, Dr. Khan achieved a Master of Education (Sci) from Allama Iqbal Open University in 2015 and a Bachelor of Education (Sci) in 2011, enhancing his educational methodologies and teaching capabilities.

💼 Professional Experience

Dr. Muhammad Saleem Khan has a robust professional trajectory centered on academia and research. Currently, he is an Assistant Professor of Zoology and In-charge of Undergraduate Studies at the University of Okara, where he has been instrumental in shaping the biological sciences curriculum and mentoring young scientists. Over his academic career, Dr. Khan has supervised numerous research projects, led collaborative studies, and managed significant research funding for innovative investigations into nanotechnology and toxicology. His professional responsibilities include designing and delivering advanced-level courses, publishing groundbreaking research in renowned journals, and fostering a research-driven academic culture. With an emphasis on interdisciplinary collaboration, he has actively engaged with national and international research networks, elevating the university’s research profile. In addition, Dr. Khan has contributed to curriculum development and served on various academic committees, demonstrating a commitment to excellence in education and scientific research.

🏅 Awards and Recognitions

Dr. Muhammad Saleem Khan’s contributions to science and education have been recognized through various accolades. He is a recipient of the Higher Education Commission’s prestigious title of Approved Supervisor, a testament to his research excellence and mentorship in higher education. His innovative research on nanomaterials and environmental toxicology has received acclaim in academic circles, leading to citations and impact factor journal features. He has presented his work at international conferences, garnering recognition for his cutting-edge methodologies and significant findings in molecular genetics and physiology. His achievements also extend to several research grants and awards, funding studies that have potential therapeutic and environmental implications. Dr. Khan’s research has not only improved scientific understanding but also led to real-world applications, making him a respected name in the scientific community. His accolades reflect a career dedicated to scientific inquiry, academic leadership, and meaningful contributions to society.

🌍 Research Skills

Dr. Muhammad Saleem Khan possesses a versatile set of research skills, encompassing advanced nanotechnology, molecular genetics, and environmental toxicology. He is adept at synthesizing and characterizing nanomaterials, conducting in vitro and in vivo experiments to evaluate biocompatibility and therapeutic potential. His expertise in toxicology allows him to assess the ecological and physiological impact of various substances, with a strong focus on aquatic organisms. Dr. Khan excels in utilizing bioinformatics tools for human molecular genetics studies, enabling him to explore genetic variations and their implications in health and disease. His research methodologies are marked by a comprehensive understanding of biostatistics and data analysis, ensuring the reliability of his scientific findings. Additionally, he is skilled in ecological and environmental assessments, leveraging his knowledge to address pressing ecological challenges. His ability to integrate multidisciplinary approaches underpins his research’s impact and innovative edge.

📖 Publication Top Notes

  • Title: Toxicity of Nano-Titanium Dioxide (TiO2-NP) Through Various Routes of Exposure: A Review
    Cited by: 331
  • Title: Synthesis, in vitro Bio-Evaluation, and Molecular Docking Study of Thiosemicarbazone-Based Isatin/Bis-Schiff Base Hybrid Analogues as Effective Cholinesterase Inhibitors
    Cited by: 101*
  • Title: Toxicity of Silver Nanoparticles in Fish: A Critical Review
    Cited by: 76
  • Title: National Prevalence Rate of Hepatitis B and C in Pakistan and Its Risk Factors
    Cited by: 72
  • Title: Assessment of Toxicity in Fresh Water Fish Labeo rohita Treated with Silver Nanoparticles
    Cited by: 72